发明名称 |
composto, composição farmacêutica, uso do composto, e, métodos de tratamento de distúrbios mediados por mglur5 e para inibição da ativação de receptores de mglur5 |
摘要 |
The invention relates to compounds of formula I or pharmaceutically acceptable salts or solvates thereof: where Ar<SUB>1</SUB>, Ar<SUB>2</SUB>, Hy, L, R<SUB>1</SUB>, m and n are as defined in the description. The invention also includes pharmaceutical compositions and uses thereof, processes for making the compounds, as well as methods for the medical treatment of mGluR5-mediated disorders. |
申请公布号 |
BRPI0615163(A2) |
申请公布日期 |
2016.09.13 |
申请号 |
BR2006PI15163 |
申请日期 |
2006.08.04 |
申请人 |
ASTRAZENECA AB |
发明人 |
ABDELMALIK SLASSI;DONALD MCLEOD;LOUISE EDWARDS;METHVIN ISAAC;TAO XIN |
分类号 |
A61K31/455;A61K31/4545;A61K31/497;A61K31/506;A61P1/00;A61P25/00;C07D401/12;C07D403/12;C07D413/12 |
主分类号 |
A61K31/455 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|